Guardant Health Inc
NASDAQ:GH
Guardant Health Inc
Operating Income
Guardant Health Inc
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Guardant Health Inc
NASDAQ:GH
|
Operating Income
-$564.7m
|
CAGR 3-Years
-30%
|
CAGR 5-Years
-43%
|
CAGR 10-Years
N/A
|
|
DaVita Inc
NYSE:DVA
|
Operating Income
$1.7B
|
CAGR 3-Years
1%
|
CAGR 5-Years
4%
|
CAGR 10-Years
-1%
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Operating Income
$1.3B
|
CAGR 3-Years
-20%
|
CAGR 5-Years
1%
|
CAGR 10-Years
2%
|
|
CVS Health Corp
NYSE:CVS
|
Operating Income
$13.6B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
3%
|
CAGR 10-Years
5%
|
|
Cigna Corp
NYSE:CI
|
Operating Income
$9.3B
|
CAGR 3-Years
3%
|
CAGR 5-Years
13%
|
CAGR 10-Years
12%
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Operating Income
$1.1B
|
CAGR 3-Years
-34%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
2%
|
See Also
What is Guardant Health Inc's Operating Income?
Operating Income
-564.7m
USD
Based on the financial report for Dec 31, 2023, Guardant Health Inc's Operating Income amounts to -564.7m USD.
What is Guardant Health Inc's Operating Income growth rate?
Operating Income CAGR 5Y
-43%
Over the last year, the Operating Income growth was -4%. The average annual Operating Income growth rates for Guardant Health Inc have been -30% over the past three years , -43% over the past five years .